Molecular Profiling-based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors

Trial Profile

Molecular Profiling-based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Oct 2017

At a glance

  • Drugs AZD-1775 (Primary) ; Carboplatin (Primary) ; Everolimus (Primary) ; Temozolomide (Primary) ; Trametinib (Primary) ; Veliparib (Primary)
  • Indications Solid tumours
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 01 Aug 2016 Status changed from not yet recruiting to recruiting, according to a results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 07 Jun 2016 Interim results (n=60) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 03 Jun 2013 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top